X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Nantahala Capital Management, LLC reported a 9.99% stake in X4 Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Nantahala Capital Management, LLC reported a 9.99% stake in X4 Pharmaceuticals, Inc., 2,244,319 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 2,244,319
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 2,244,319 |
| Wilmot B. Harkey | 9.99% | 2,244,319 |
| Daniel Mack | 9.99% | 2,244,319 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Nantahala Capital Management, LLC
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Feb 13, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026